Reading this on a mobile device? Try our optimized mobile version here:

November 26, 2012
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  • US Radiopharmaceuticals enters isotope deal with ANSTO
    US Radiopharmaceuticals and the Australian Nuclear Science and Technology Organization have entered a deal that will enable USR to make Australian-designed technetium-99m generators using low-enriched-uranium-based molybdenum-99. As part of the agreement, USR will open a technetium-99m generator production facility in Denton, Texas, that is expected to be operational in the fourth quarter of 2013. "We anticipate our announcement today will go some way to alleviate the U.S. government's concerns associated with nonproliferation and also address recent technetium generator shortages in the U.S. nuclear medicine community," said USR CEO Paul Crowe. PR Web/News release (11/24) LinkedInFacebookTwitterEmail this Story
  Clinical News & Research 
  • Study offers insight on effects of anesthesia on children
    Children given the general anesthetic sevoflurane showed higher levels of lactate and glucose in the brain compared with those given propofol, according to a study that used MR spectroscopy to measure those levels. The patients' delirium risk decreased with growing total creatine concentrations and increased with rising lactate and glucose levels, according to the study in Anesthesiology. "As an increasingly young patient population continues to have a growing need for general anesthesia, it is important to determine the impact inhalant and intravenous anesthetics have on children," the researchers said. News-Medical.Net/medwireNews (11/21) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  • NIH extends contracts for proteomics studies
    The NIH extended contracts worth $9.1 million in the first year -- with an increasing value of up to $52.4 million over five years if specific scientific goals are reached -- to Seattle Biomedical Research Institute, Emerald Biostructures, the Pacific Northwest National Laboratory and others for their work on determining how protein structure affects disease. Researchers hope the work will become a resource for developing drugs, vaccines and diagnostics to fight a variety of diseases. Xconomy/Seattle (11/19) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • U.K. center seeks to advance personalized medicine
    The Royal Marsden hospitals and The Institute of Cancer Research in the U.K. have formed the Centre for Molecular Pathology, a multidisciplinary research center that will focus on advancing personalized medicine. The facility will conduct "smart" clinical trials to determine whether cancer drugs are reaching their molecular targets. The center will also aim to create molecular biomarkers and pinpoint new molecular targets for various types of tumors. PharmaTimes (U.K.) (11/22) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Nuclear medicine, radiology to face coding changes in 2013
    Industry coding experts said providers should prepare for CMS coding changes in three areas -- cervical spine, nuclear medicine and interventional radiology -- in 2013. These changes will take effect Jan. 1 and will focus on the head and neck, particularly regarding radiology, experts said. CMS is also set to issue a new code structure next year for nuclear medicine. The agency's moves are in line with its shift to bundling more codes that regularly show up together. Diagnostic Imaging (11/21) LinkedInFacebookTwitterEmail this Story
  • Custom device proposed rules now in comment phase
    The FDA is requesting public comment on the proposed criteria for its custom medical device exemption system after some revisions were made via the FDA Safety & Innovation Act. The notice calls for "information on and examples of appropriate uses" of the system, particularly from patients, manufacturers, doctors and dentists. (Boston) (11/23) LinkedInFacebookTwitterEmail this Story
  • FDA needs track-and-trace system for biosimilars
    The FDA should establish a track-and-trace system to monitor biosimilars, as well as a naming system to distinguish biologics from biosimilars to protect patients, writes Dr. Bert Petersen of the New York University School of Medicine. Tracking can help the health system identify and respond to issues such as the recent meningitis outbreak. Furthermore, doctors must decide the suitable biologic drug for a patient, a decision that can't be overridden by an insurance company or a pharmacist, Petersen writes. The Hill/Congress Blog (11/20) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Online messaging system allows docs to securely access patient data
    A secure Web-based phone messaging system and network for doctors known as PriorUs is being developed by Electronic Medical Solutions and piloted by nearly 50 primary care doctors and hospitalists in Kansas. The system, which complies with the Health Insurance Portability and Accountability Act, can track the data being viewed by users, as doctors are required to enter their PIN to access the network. (11/21) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • SNMMI 2013 Annual Meeting virtual exhibit hall is LIVE!
    The virtual exhibit hall for the SNMMI 2013 Annual Meeting, June 8-12, 2013, in Vancouver, British Columbia, is live! Visit the virtual exhibit hall and experience 24/7 search capabilities by company name, booth number and product category. Attendees can e-mail exhibitors with questions, request appointments and plan their time/map their route in the exhibit hall. Don't miss this great opportunity to get acquainted with the exhibit hall layout and exhibitors before the conference! LinkedInFacebookTwitterEmail this Story
  • Summary of CY 2013 HOPPS and MPFS final rules
    Earlier this month, the Centers for Medicare and Medicaid Services issued the CY 2013 Final Rules for the Hospital Outpatient Prospective Payment System (HOPPS) and Medicare Physician Fee Schedule (MPFS). See the final rules here. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

The passion for setting people right is in itself an afflictive disease."
--Marianne Moore,
American poet and writer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.®  Legal Information